Trial
NCT02966171
A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients With Advanced Solid Malignancies
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Hutchison Medipharma Limited
Collaborators
—
Condition
Solid Tumor
Intervention
HMPL-453
Why stopped
The study was terminated on 23AUG2018 for safety reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-21